First report of pulmonary large cell neuroendocrine carcinoma treated with stereotactic body radiation therapy
ConclusionsThis first report of SBRT for pulmonary LCNEC demonstrates that SBRT is a feasible modality for this rare disease. A multidisciplinary thoracic oncology approach involving medical oncology, thoracic surgery, radiation oncology and pulmonology is strongly recommended to ensure proper patient selection for receipt of SBRT.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer | Cancer & Oncology | Carcinoma | Cardiovascular & Thoracic Surgery | Chemotherapy | Lung Cancer | Neurology | Neurosurgery | Non-Small Cell Lung Cancer | Radiation Therapy | Rare Diseases | Study